A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

Clinical trial NCT01074125 · COMPLETED

Trial details

NCT number: NCT01074125
Sponsor: Keryx Biopharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hyperphosphatemia End-Stage Renal Disease

Start date: 2010-05-01
Primary completion: 2010-11-01
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.